81 reports

Abstract: - Global Antifungal Drugs Market to Reach $17.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antifungal Drugs estimated at US$14.9 Billion in the year 2020, is projected to reach a revised size of US$17.5 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027. Azoles,...

  • Antifungal
  • World
  • China
  • United States

Report Scope: The aim of this report is to initially conduct a review of the antifungal drugs currently available, explore the issues facing the use of antifungal drugs and review some of the latest developments of new and innovative antifungal drugs, their technologies and their intended clinical applications. The key...

  • Antifungal
  • World
  • Generics Use

Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories. The global antifungals market is expected to grow from $9.98 billion in 2020 to $10.29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The growth is mainly due to the companies rearranging their operations...

  • Antifungal
  • World

## Europe Antifungal Drugs Market

  • Antifungal
  • APAC
  • World
  • Cancer Incidence
  • Health Expenditure

Global Antifungal Drugs Market

  • Antifungal
  • World
  • APAC
  • Europe
  • North America
  • China
  • Canada
  • Japan
  • Germany
  • Health Expenditure
  • HIV AIDS Prevalence

Global Antifungal Drugs Market 2020-2024 The analyst has been monitoring the antifungal drugs market and it is poised to grow by USD 2.50 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period. Our reports on antifungal drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Antifungal
  • World

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025 The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to...

  • Antifungal
  • World
  • HIV AIDS Prevalence

‘Candidemia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Candidemia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Candidemia Disease Understanding Candidemia is defined as the presence of Candida...

  • Hospital
  • Epidemiology
  • Antifungal
  • Germany
  • United States
  • United Kingdom
  • Spain
  • Japan
  • France
  • Italy
  • World
  • Hospital Occupancy Rate
  • Hospital Admission

Abstract: - Global Antimicrobial Ingredients Market to Reach 94.1 Thousand Tons by 2027 - Amid the COVID-19 crisis, the global market for Antimicrobial Ingredients estimated at 78.2 Thousand Tons in the year 2020, is projected to reach a revised size of 94.1 Thousand Tons by 2027, growing at a CAGR of 2.7% over the...

  • Antifungal
  • Antiviral
  • Antiseptics
  • Anti-Infective
  • World
  • China
  • United States

KEY FINDINGS The global antifungal agents market is chiefly being propelled by factors like poor hygiene habits, supportive policies and programs by government and the development of drug resistance. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 3.72%. MARKET INSIGHTS The...

  • Antifungal
  • World
  • APAC

‘Candidemia – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Candidemia market report provides current treatment...

  • Therapy
  • Antifungal
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Hospital Admission

World Antifungal Infectious Disease Therapy

  • Antifungal
  • Infectious Disease
  • World

World Infectious Disease Antifungal Cystic Fibrosis Biotechnology Therapy

  • Therapy
  • Infectious Disease
  • Antifungal
  • World
  • Mortality Rate
  • Drug Approval

Innovative classes of antifungals have recently become accessible with wider antifungal activity, less drug-drug interactions, and enhanced tolerability when compared with the older antifungal agents.

  • Antifungal
  • World
  • HIV AIDS Prevalence
  • HIV Incidence

iNtRON Biotechnology Inc conducted a study to investigate the antifungal activities of iN-EYD## in clinical isolates from patients with fungal meningitis (cryptococcosis).

  • Antifungal
  • Infectious Disease
  • World
  • Stem Cell Transplantation
  • Drug Approval

NovaBiotics announced that that it has further strengthened the global intellectual property position of its lead product Novexatin with a recent patent grant in the US for the company's under-pinning antifungal peptide platform technology.

  • Antifungal
  • Pharmaceutical
  • Infectious Disease
  • Dermatological Condition
  • World
  • South Africa
  • Dropout Rate
  • Drug Approval

In June 2007, Novabiotics Ltd filed a patent application (PCT/GB2007/002062) entitled Use of coumarin derivatives in antifungal therapy".

  • Antifungal
  • Infectious Disease
  • Dermatological Condition
  • World
  • South Africa
  • Dropout Rate
  • Drug Approval

World Infectious Disease Antifungal Therapy

  • Antifungal
  • Infectious Disease
  • World

About this market Advances in diagnosis of antifungal resistant pathogens to drive market growth. Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs. For instance, Candida auris, an emerging antifungal¬resistant yeast, is...

  • Infectious Disease
  • Antifungal
  • World

In June 2007, Novabiotics Ltd filed a patent application (PCT/GB2007/002062) entitled Use of coumarin derivatives in antifungal therapy".

  • Antifungal
  • Infectious Disease
  • Dermatological Condition
  • World
  • South Africa
  • Indiana
  • Drug Approval

“FOSMANOGEPIX- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Candidemia in 7 Major Markets. A detailed picture of the FOSMANOGEPIX in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...

  • Antifungal
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

This study covers the world outlook for antifungal pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • Pharmaceutical
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for topical antifungal medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • World
  • Gross Domestic Product
  • Disposable Income

When the current global crisis has abated, efforts must turn to future preventative measures Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses and are up to 1000 times more efficient than previous technologies available on the market They can work on multiple levels at the same time:...

  • Antiviral
  • Antiseptics
  • Antifungal
  • World

KEY FINDINGS Huge investments made for drug productions, along with the government initiatives related to fungal infections and their treatment are driving growth in the North America antifungal agents market. Over the forecast years of 2018-2026, the market is likely to showcase a CAGR of 2.80%. MARKET INSIGHTS Canada...

  • Antifungal
  • North America
  • World
  • United States

This study covers the world outlook for at-home vaginal antifungal treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antifungal
  • World
  • Gross Domestic Product
  • Disposable Income

KEY FINDINGS Asia Pacific antifungal agent market is being driven by factors like poor hygiene in the region, the development of new antifungal drugs and supportive government programs. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 5.39%. MARKET INSIGHTS The...

  • Antifungal
  • APAC

KEY FINDINGS The spectrum of fungal infections ranges from the localized skin and soft tissue infections to fungemia, with disseminated disease to almost any organ system.In recent years, the prevalence of such infections has multiplied considerably, thus increasing the market demand for antifungal agents. Over the...

  • Antifungal
  • Europe

United States Epidemiology Acne Treatment Antifungal Infectious Disease

  • Antifungal
  • Infectious Disease
  • United States
  • Prescription Drug Sales
  • Breast Screening Coverage

China East Asia Antifungal

  • Dermatological Treatment
  • Anti-Infective
  • Antifungal
  • China
  • Industrial Production
  • Labour Force